Doebele R, et al. Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). IASLC 2018; abstract OA02.01.
Constitutionele BRCA1-methylering geassocieerd met risico op borst- en eierstokkanker
okt 2022 | Borstkanker, Gynaecologische oncologie